Thoracoscopy-assisted magnetic resonance guided microwave coagulation therapy for hepatic tumors

被引：29

作者：

Shiomi, Hisanori ^{[1
]}

Naka, Shigeyuki ^{[1
]}

Sato, Koichirou ^{[1
]}

Demura, Kouichi ^{[1
]}

Murakami, Kouichi ^{[1
]}

Shimizu, Tomoharu ^{[1
]}

Morikawa, Shigehiro ^{[1
]}

Kurumi, Yoshimasa ^{[1
]}

Tani, Tohru ^{[1
]}

机构：

[1] Shiga Univ Med Sci, Div Gastrointestinal Surg, Dept Surg, Shiga 5202192, Japan

来源：

AMERICAN JOURNAL OF SURGERY | 2008年 / 195卷 / 06期

基金：

日本科学技术振兴机构;

关键词：

hepatic tumor; microwave coagulation therapy; real-time magnetic resonance image; interventional magnetic resonance image;

D O I：

10.1016/j.amjsurg.2007.08.056

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

BACKGROUND: Microwave coagulation therapy (MCT) has become a safe and effective modality with which to treat hepatic tumors; MCT can be applied percutaneously, laparoscopically, thoracoscopically, and during laparotomy. When combined with magnetic resonance (MR) imaging, MCT can be used to treat hepatic tumors located in the subdiaphragmatic area that are difficult to approach by ultrasound, because of the overlaying lower lung field. METHODS: To determine the usefulness of thoracoscopy-assisted interventional MR-MCT (T-IVMR-MCT, n = 73), we compared patients with hepatic tumors that were treated with percutaneous IVMR-MCT (P-IVMR-MCT, n = 69) and with T-IVMR-MCT. RESULTS: None of patient background, complication and recurrence rate, or length of hospital stay significantly differed between the 2 groups. CONCLUSIONS: IVMR-MCT is a useful modality for treating hepatic tumors. Especially when tumors are located at the hepatic dome, T-IVMR-MCT was minimally invasive, while it appears to improve targeting of peridiagmatic hepatic lesions and has a complication profile similar to P-IVMR-MCT. (C) 2008 Elsevier Inc. All rights reserved.

引用

页码：854 / 860

页数：7

共 25 条

[1]

Abe T, 2000, ENDOSCOPY, V32, P598

[2]

Asahara Toshimasa, 1998, Hiroshima Journal of Medical Sciences, V47, P125

[3] Underlying liver disease, not tumor factors, predicts long-term survival alter resection of hepatocellular carcinoma [J].

Bilimoria, MM ;

Lauwers, GY ;

Doherty, DA ;

Nagorncy, DM ;

Belghiti, J ;

Do, KA ;

Regimbeau, JM ;

Ellis, LM ;

Curley, SA ;

Ikai, I ;

Yamaoka, Y ;

Vauthey, JN .

ARCHIVES OF SURGERY, 2001, 136 (05) :528-534

[4] Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy [J].

Bismuth, H ;

Adam, R ;

Levi, F ;

Farabos, C ;

Waechter, F ;

Castaing, D ;

Majno, P ;

Engerran, L .

ANNALS OF SURGERY, 1996, 224 (04) :509-520

[5] Epidemiology of primary liver cancer [J].

Bosch, FX ;

Ribes, J ;

Borràs, J .

SEMINARS IN LIVER DISEASE, 1999, 19 (03) :271-285

[6] Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference [J].

Bruix, J ;

Sherman, M ;

Llovet, JM ;

Beaugrand, M ;

Lencioni, R ;

Burroughs, AK ;

Christensen, E ;

Pagliaro, L ;

Colombo, M ;

Rodés, J .

JOURNAL OF HEPATOLOGY, 2001, 35 (03) :421-430

[7] Minimally invasive treatment of malignant hepatic tumors: At the threshold of a major breakthrough [J].

Dodd, GD ;

Soulen, MC ;

Kane, RA ;

Livraghi, T ;

Lees, WR ;

Yamashita, Y ;

Gillams, AR ;

Karahan, OI ;

Rhim, H .

RADIOGRAPHICS, 2000, 20 (01) :9-27

[8] Thermal ablation for hepatocellular carcinoma [J].

Head, HW ;

Dodd, GD .

GASTROENTEROLOGY, 2004, 127 (05) :S167-S178

[9] Microwave coagulation therapy for liver cancer: laparoscopic microwave coagulation [J].

Ido, K ;

Isoda, N ;

Sugano, K .

JOURNAL OF GASTROENTEROLOGY, 2001, 36 (03) :145-152

[10] Thoracoscopic thermal ablation therapy for hepatocellular carcinoma located beneath the diaphragm [J].

Ishikawa, T ;

Kohno, T ;

Shibayama, T ;

Fukushima, Y ;

Obi, S ;

Teratani, T ;

Shiina, S ;

Shiratori, Y ;

Omata, M .

ENDOSCOPY, 2001, 33 (08) :697-702

← 1 2 3 →